Viking Therapeutics
VKTX
VKTX
148 hedge funds and large institutions have $753M invested in Viking Therapeutics in 2018 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
28% more funds holding
Funds holding: 116 → 148 (+32)
7.55% more ownership
Funds ownership: 53.84% → 61.39% (+7.6%)
4% less call options, than puts
Call options by funds: $35.3M | Put options by funds: $37M
Holders
148
Holding in Top 10
3
Calls
$35.3M
Puts
$37M
Top Buyers
| 1 | +$126M | |
| 2 | +$92.7M | |
| 3 | +$20M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$14.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$14.6M |
Top Sellers
| 1 | -$42.4M | |
| 2 | -$35.6M | |
| 3 | -$20.4M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$7.12M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$6.53M |